Trial Outcomes & Findings for Psychological Symptoms and Families of COVID-19 Patients (NCT NCT04501445)

NCT ID: NCT04501445

Last Updated: 2023-04-27

Results Overview

Score on Impact of Events Scale Revised (IES-R) questionnaire. 22 questions. Score 0-88 with higher scores indicating more stress.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

90 participants

Primary outcome timeframe

Measured once upon enrollment

Results posted on

2023-04-27

Participant Flow

Subjects who completed surveys after ICU discharge

Participant milestones

Participant milestones
Measure
Surveyed After ICU Discharge
Surveyed after ICU discharge
Overall Study
STARTED
90
Overall Study
COMPLETED
90
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Psychological Symptoms and Families of COVID-19 Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Surveyed After ICU Discharge
n=90 Participants
Surveyed after ICU discharge
Age, Categorical
<=18 years
1 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
84 Participants
n=5 Participants
Age, Categorical
>=65 years
5 Participants
n=5 Participants
Age, Continuous
49 years
STANDARD_DEVIATION 12 • n=5 Participants
Sex: Female, Male
Female
72 Participants
n=5 Participants
Sex: Female, Male
Male
18 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
49 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
40 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
18 Participants
n=5 Participants
Race (NIH/OMB)
White
14 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
58 Participants
n=5 Participants
Region of Enrollment
United States
90 participants
n=5 Participants

PRIMARY outcome

Timeframe: Measured once upon enrollment

Score on Impact of Events Scale Revised (IES-R) questionnaire. 22 questions. Score 0-88 with higher scores indicating more stress.

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=90 Participants
Survey after ICU discharge
Symptoms of Post-Traumatic Stress Disorder (PTSD) Initial
27.9 score on a scale
Standard Deviation 17.9

PRIMARY outcome

Timeframe: Measured once upon enrollment

Score on Hospital Anxiety and Depression Scale (HADS). Total score 0-21 for anxiety (7 questions) and 0-21 for depression (7 questions). Higher scores indicate greater symptom burden.

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=90 Participants
Survey after ICU discharge
Symptoms of Anxiety and Depression Initial
12.8 score on a scale
Standard Deviation 8.9

SECONDARY outcome

Timeframe: Measured once upon enrollment

Score on the Critical Care Family Needs Inventory (CCFNI) questionnaire. 14 questions. Total score range 14-56 with lower scores indicating better satisfaction.

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=90 Participants
Survey after ICU discharge
Surrogate Satisfaction With the Patient's ICU Care:
16.8 score on a scale
Standard Deviation 6.0

SECONDARY outcome

Timeframe: Measured before behavioral intervention (6-12 weeks after enrollment)

IES-R score before intervention The IES-R yields a total score (ranging from 0 to 88) with higher scores indicative of more severe PTSD

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=26 Participants
Survey after ICU discharge
Symptoms of Post-Traumatic Stress Disorder (PTSD) Final
36.9 score on a scale
Standard Deviation 17.0

SECONDARY outcome

Timeframe: Measured after behavioral intervention (12-24 weeks after enrollment)

IES-R after intervention The IES-R yields a total score (ranging from 0 to 88) with higher scores indicative of more severe PTSD

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=19 Participants
Survey after ICU discharge
Symptoms of Post-Traumatic Stress Disorder (PTSD) Final
24.1 score on a scale
Standard Deviation 13.5

SECONDARY outcome

Timeframe: Measured before behavioral intervention (6-12 weeks after enrollment)

Score on Hospital Anxiety and Depression Scale (HADS). Total score 0-21 for anxiety (7 questions) and 0-21 for depression (7 questions). Higher scores indicate greater symptom burden.

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=26 Participants
Survey after ICU discharge
Symptoms of Anxiety and Depression Final
15.9 score on a scale
Standard Deviation 9.4

SECONDARY outcome

Timeframe: Measured after behavioral intervention (12-24 weeks after enrollment)

Score on Hospital Anxiety and Depression Scale (HADS). Total score 0-21 for anxiety (7 questions) and 0-21 for depression (7 questions). Higher scores indicate greater symptom burden.

Outcome measures

Outcome measures
Measure
Surveyed After ICU Discharge
n=19 Participants
Survey after ICU discharge
Symptoms of Anxiety and Depression Final
11.7 score on a scale
Standard Deviation 7.0

SECONDARY outcome

Timeframe: Measured once upon enrollment

Qualitative analysis of phone interview to determine the presence and reason(s) for psychological symptoms

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured after behavioral intervention (12-24 weeks after enrollment)

Qualitative analysis of phone interview to determine the presence and reason(s) for psychological symptoms

Outcome measures

Outcome data not reported

Adverse Events

Received Group Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jared A Greenberg

Rush University Medical Center

Phone: 312-942-6744

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place